Note: This document contains side effect information about phentermine / topiramate. Some dosage forms listed on this page may not apply to the brand name Qsymia.
Summary
Common side effects of Qsymia include: constipation, insomnia, nasopharyngitis, paresthesia, mood disorder, sleep disorder, and xerostomia. Other side effects include: urinary tract infection, anxiety, blurred vision, depression, dizziness, fatigue, influenza, nausea, increased serum creatinine, and dysgeusia. Continue reading for a comprehensive list of adverse effects.
Applies to phentermine / topiramate: oral capsule extended release.
Serious side effects of Qsymia
Along with its needed effects, phentermine/topiramate may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking phentermine / topiramate:
Less common
- Chest discomfort
- decreased urine
- dry mouth
- fast, irregular, pounding, or racing heartbeat or pulse
- loss of appetite
- mood changes
- muscle pain or cramps
- nausea or vomiting
- numbness or tingling in the hands, feet, or lips
- seizures
- trouble breathing
- unusual tiredness or weakness
Rare
- Blood in the urine
- pain in the groin or genitals
- sharp back pain just below the ribs
Incidence not known
- Blistering, peeling, or loosening of the skin
- blisters on the mouth, trunk, scalp, or other areas
- blurred or decreased vision
- chest pain
- chills or shivering
- clumsiness
- continuing nausea or vomiting
- cough or sore throat
- dark urine
- diarrhea or light-colored stools
- dizziness
- headache
- increase in the frequency of seizures
- irregular heartbeat
- itching
- joint or muscle pain
- loss of appetite
- low body temperature
- muscle aches or weakness
- pain in the shoulders, arms, jaw, or neck
- red skin lesions, often with a purple center
- red, irritated eyes
- shakiness in the legs, arms, hands, or feet
- sores, ulcers, or white spots in the mouth or on the lips
- sweating
- swelling of the face
- tiredness and weakness
- trouble thinking, speaking, or walking
- upper right abdominal or stomach pain
- weak or feeble pulse
- weight gain
- yellow eyes or skin
Other side effects of Qsymia
Some side effects of phentermine / topiramate may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- Back pain
- change in taste
- difficulty having a bowel movement (stool)
- ear congestion
- fear or nervousness
- loss of taste
- loss of voice
- memory problems
- pain or tenderness around the eyes and cheekbones
- sneezing
- stuffy or runny nose
- trouble sleeping
Less common
- Belching
- cramps
- decreased appetite
- dry eyes
- eye pain
- hair loss
- heartburn or indigestion
- heavy bleeding
- irritability
- pain in the arms or legs
- rash
- stomach discomfort, upset, or pain
Incidence not known
- Bloating
- false or unusual sense of well-being
- feeling that others are watching you or controlling your behavior
- feeling that others can hear your thoughts
- feeling, seeing, or hearing things that are not there
- hives or welts
- change in sexual ability, desire, drive, or performance
- severe mood or mental changes
- unusual behavior
For Healthcare Professionals
Applies to phentermine / topiramate: oral capsule extended release.
Nervous system
Very common (10% or more): Paraesthesia (up to 19.9%), headache (up to 10.6%)
Common (1% to 10%): Dysgeusia, dizziness, hypoesthesia, disturbance in attention, cognitive impairment
Phentermine:
Postmarketing reports: Euphoria, psychosis, tremor[Ref]
Psychiatric
Common (1% to 10%): Insomnia, anxiety, depression/mood problems, irritability
Postmarketing reports: Suicidal ideation, suicidal behavior
Phentermine:
Postmarketing reports: Libido changes, impotence[Ref]
Metabolic
Very common (10% or more): Decreased serum bicarbonate (up to 12.8%)
Common (1% to 10%): Hypokalemia, decreased serum potassium, decreased appetite
Topiramate:
Postmarketing reports: Hyperammonemia[Ref]
Renal
Common (1% to 10%): Elevated serum creatinine, nephrolithiasis[Ref]
Cardiovascular
Very common (10% or more): Elevated resting heart rate (up to 77.7%)
Common (1% to 10%): Palpitations
Phentermine:
Postmarketing reports: Elevated blood pressure, ischemic events[Ref]
Ocular
Common (1% to 10%): Blurred vision, dry eye, eye pain
Postmarketing reports: Acute angle closure glaucoma, increased intraocular pressure
Topiramate:
Postmarketing reports: Maculopathy[Ref]
Other
Common (1% to 10%): Fatigue, thirst, chest discomfort, procedural pain
Topiramate:
Postmarketing reports: Hypothermia[Ref]
General
Common adverse reactions occurring at a rate of 5% or more and at a rate of at least 1.5 times placebo include paraesthesia, dizziness, dysgeusia, insomnia, constipation, and dry mouth.[Ref]
Dermatologic
Common (1% to 10%): Alopecia, rash
Topiramate:
Frequency not reported: Oligohidrosis
Postmarketing reports: Bullous skin reactions (including erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis), pemphigus[Ref]
Gastrointestinal
Very common (10% or more): Dry mouth (up to 19.1%), constipation (up to 16.1%)
Common (1% to 10%): Nausea, diarrhea, gastroesophageal reflux disease, dyspepsia, oral paraesthesia, gastroenteritis
Topiramate:
Postmarketing reports: Pancreatitis[Ref]
Genitourinary
Common (1% to 10%): Dysmenorrhea, urinary tract infection[Ref]
Hepatic
Topiramate:
Postmarketing reports: Hepatic failure (including fatalities), hepatitis[Ref]
Hypersensitivity
Phentermine:
Postmarketing reports: Urticaria[Ref]
Immunologic
Common (1% to 10%): Influenza[Ref]
Musculoskeletal
Common (1% to 10%): Back pain, extremity pain, muscle spasms, musculoskeletal pain, neck pain[Ref]
Respiratory
Very common (10% or more): Upper respiratory tract infection (up to 15.8%), nasopharyngitis (up to 12.5%)
Common (1% to 10%): Sinusitis, bronchitis, cough, sinus congestion, pharyngolaryngeal pain, nasal congestion[Ref]